ライフサイエンスコーパス: sarcoma virus

1 d 2, simian immunodeficiency virus, and Rous sarcoma virus.

2 n that is present in the Gag protein of Rous sarcoma virus.

3 .5 of herpes simplex virus and NL-S of avian sarcoma virus.

4 dermal sarcoma virus and salmon swim bladder sarcoma virus.

5 fied in the gag-specific protein p2b of Rous sarcoma virus.

6 irus with significant homology to the simian sarcoma virus.

7 ogue of v-src, the transforming gene of Rous Sarcoma virus.

8 sed by gamma-herpesviruses, such as Kaposi's sarcoma virus.

9 es of two in-vitro-assembled capsids of Rous sarcoma virus.

10 irus type 1, hepatitis C virus, and Kaposi's sarcoma virus.

11 of the naturally nonmyristoylated MA of Rous sarcoma virus.

12 The retroviral oncogene p3k (v-p3k) of avian sarcoma virus 16 (ASV16) codes for the catalytic subunit

13 en embryo fibroblasts (CEF) infected by Rous sarcoma virus against a confluent background of uninfect

14 brane subunit (TM) of the avian leukosis and sarcoma virus (ALSV) envelope glycoprotein (Env) contain

15 We are using avian leukosis-sarcoma virus (ALSV) vectors to generate mouse tumor mod

16 r receptor for subgroup A avian leukosis and sarcoma virus (ALSV-A).

17 The avian leukosis-sarcoma virus (ALV) group of retroviruses provides a use

18 ell dramatically reduced the release of Rous sarcoma virus, an avian retrovirus.

19 Despite sequence differences between avian sarcoma virus and HIV-1 IN and their recognition sequenc

20 eferred in vitro integration sites for avian sarcoma virus and human immunodeficiency virus-1 integra

21 Harvey sarcoma virus and Moloney murine leukemia virus construc

22 SU and TM envelope protein subunits of Rous sarcoma virus and murine leukemia virus.

23 outbreaks of disease, such as walleye dermal sarcoma virus and salmon swim bladder sarcoma virus.

24 Tva is the receptor for subgroup A Rous sarcoma virus, and it contains a single LDL-A module whi

25 (DR) sequences flanking the src gene in Rous sarcoma virus are essential posttranscriptional control

26 eriments reported here, using the avian Rous sarcoma virus as a model system, further define the natu

27 s seen in the integrase core domain of avian sarcoma virus as well as human immunodeficiency virus ty

28 protein are intrinsic components of the Rous sarcoma virus assembly pathway.

29 d independently of catalysis with both avian sarcoma virus (ASV) and human immunodeficiency virus typ

30 the core domain of integrase (IN) from avian sarcoma virus (ASV) and its active-site derivative conta

31 The direct-repeat elements (dr1) of avian sarcoma virus (ASV) and leukosis virus have the properti

32 immunodeficiency virus type 1 (HIV-1), avian sarcoma virus (ASV) and their close orthologs from the L

33 Recent studies have demonstrated that avian sarcoma virus (ASV) can transduce cycle-arrested cells.

34 We have described a reconstituted avian sarcoma virus (ASV) concerted DNA integration system wit

35 Using a model system in which avian sarcoma virus (ASV) DNA is epigenetically repressed in m

36 ubiquitin ligases bind the L domain in avian sarcoma virus (ASV) Gag and facilitate viral particle re

37 Reverse transcription in avian sarcoma virus (ASV) initiates from the 3' end of a tRNA(

38 HIV-1, simian sarcoma virus (SIV), and avian sarcoma virus (ASV) INs predicted which of these residue

39 x was identified as an interactor with avian sarcoma virus (ASV) integrase (IN) in a yeast two-hybrid

40 ined the size and shape of full-length avian sarcoma virus (ASV) integrase (IN) monomers and dimers i

41 In contrast, integration by avian sarcoma virus (ASV) integrase was more efficient after c

42 Here, we report the mapping of 226 avian sarcoma virus (ASV) integration sites in the human genom

43 arable to one previously described for avian sarcoma virus (ASV) that was stimulated by the presence

44 ntegrase protein of an oncoretrovirus, avian sarcoma virus (ASV), suggesting an active import mechani

45 repression and silencing of integrated avian sarcoma virus (ASV)-based vector DNAs in human HeLa cell

46 requirement for the simple retrovirus, avian sarcoma virus (ASV).

47 cell populations that harbored silent avian sarcoma virus-based green fluorescent protein (GFP) vect

48 egration catalyzed by HIV-1 to that of avian sarcoma virus by analyzing the effect of defined mutatio

49 allowed for the first-time formation of Rous sarcoma virus CA into structures resembling authentic ca

50 Instead, the Rous sarcoma virus capsid protein contains a single cysteine

51 lar disulfide bond during assembly, the Rous sarcoma virus capsid protein does not.

52 arged amino acids on the surface of the Rous sarcoma virus capsid protein in the assembly of appropri

53 quence similarity, the structure of the Rous sarcoma virus capsid protein is similar to the structure

54 that exist in the C-terminal domain of Rous sarcoma virus capsid relative to the other capsid protei

55 ly unrelated late domain sequences from Rous sarcoma virus (contained in its p2b sequence) or equine

56 kinase substrates and identified CRKL (v-Crk sarcoma virus CT10 oncogene-like protein), a substrate o

57 Using the Rous sarcoma virus-derived vector RCAS, we previously showed

58 Since codon composition values for Rous sarcoma virus distinguished a "foreign" gene from the re

59 Simple retroviruses, such as avian sarcoma virus, do not encode regulatory proteins that af

60 Walleye dermal sarcoma virus encodes a retroviral cyclin (RV-cyclin) th

61 ted the modified MND LTR (myeloproliferative sarcoma virus enhancer, negative control region deleted,

62 ficiency virus type 1, visna virus, and Rous sarcoma virus exhibited distinct preferences for water o

63 ken embryos with replication-competent avian sarcoma virus expressing either FgfR2(C278F), a receptor

64 no acid level) to that of the avian leukosis-sarcoma virus family, it retains several sequences of de

65 ntisense to fau (Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV)-associated ubiquitously express

66 that while deletion of the NC domain of Rous sarcoma virus Gag abolishes formation and budding of VLP

67 Using purified Rous sarcoma virus Gag and Gag truncations, we studied the in

68 (VLPs), we observed that expression of Rous sarcoma virus Gag failed to produce VLPs.

69 The Rous sarcoma virus gag gene contains a cis-acting negative re

70 of the CA domains in immature assembled Rous sarcoma virus Gag particles.

71 In the context of the Rous sarcoma virus Gag polyprotein, only the nucleocapsid (NC

72 It was shown previously that a Rous sarcoma virus Gag protein missing only the protease doma

73 The Rous sarcoma virus Gag protein undergoes transient nuclear tr

74 fied, slightly truncated version of the Rous sarcoma virus Gag protein, Delta MBD Delta PR, and DNA o

75 nce correlation spectroscopy-to examine Rous sarcoma virus Gag-Gag and -membrane interactions in livi

76 e indicated that in the context of the avian sarcoma virus genome, precise deletion of both ASV dr1 e

77 ng signal, MPsi, from the 5' end of the Rous sarcoma virus genome.

78 osed that dimerization of the Moloney murine sarcoma virus genomic RNAs relies upon the concentration

79 no acid residue capsid protein from the Rous sarcoma virus has been determined by NMR methods.

80 Six predicted Kaposi's sarcoma virus herpesvirus (KSHV) proteins have homology

81 The low molecular weight G protein RhoA (rat sarcoma virus homolog family member A) serves as a node

82 In avian leukosis-sarcoma virus, however, we have shown that the minimal p

83 anganate modification to show that the avian sarcoma virus IN catalytic domain is able to distort vir

84 ture of the three-domain integrase from Rous sarcoma virus in complex with viral and target DNAs.

85 tive sequence (MiDAS) for the Moloney murine sarcoma virus in the final dimer state using selective 2

86 ast, CEF cultures heavily infected with Rous sarcoma virus in the same medium underwent pervasive tra

87 putative dimer-dimer interface of the avian sarcoma virus IN with its analogue, loop188-194, from hu

88 ategy, the unique amino acids found in avian sarcoma virus IN, rather than HIV-1 or Mason-Pfizer monk

89 air (bp) laboratory-generated Moloney murine sarcoma virus, induced subcutaneous tumors in about 14%

90 The myeloproliferative sarcoma virus induces spleen focus formation in vivo and

91 rosine-phosphorylated when expressed in Rous sarcoma virus-infected chicken embryo fibroblasts (RSV-C

92 tudies of the catalytic core domain of avian sarcoma virus integrase (ASV IN) have provided the most

93 omplex of the catalytic core domain of avian sarcoma virus integrase (ASV IN) were solved at 1.9- to

94 positions in visna virus integrase and Rous sarcoma virus integrase changed the target site preferen

95 tudies revealed that truncated forms of Rous sarcoma virus integrase containing two of the three prot

96 an immunodeficiency virus-1 integrase, avian sarcoma virus integrase, and bacteriophage Mu transposas

97 Using the avian sarcoma virus integrase, we demonstrate that the enzyme

98 st sequences, as is characteristic for avian sarcoma virus integration.

99 A direct comparison demonstrates that Rous sarcoma virus is capable of infecting aphidicolin-arrest

100 Examination of the genomes of three Rous sarcoma virus isolates indicated that codon composition

101 fau) increased the tumorigenicity of a mouse sarcoma virus, it was proposed that fau might be a tumor

102 ed a small segment of the 3' end of the Rous sarcoma virus, just inside the poly(A) tail, at the same

103 ropic virus (HTLV-1) and Kaposi's associated sarcoma virus (KSHV) contribute to 10-15% of the cancers

104 estigated the features of the Moloney murine sarcoma virus leader sequence necessary for RNA packagin

105 susceptible mice with the myeloproliferative sarcoma virus leads to the formation of erythroid bursts

106 ing chicken Y-box protein that promotes Rous sarcoma virus long terminal repeat (RSV LTR)-driven tran

107 chimeric transcription factor on the Moloney sarcoma virus long terminal repeat and a synthetic promo

108 to the levels observed in vivo with the Rous sarcoma virus long terminal repeat constitutive promoter

109 iotic-resistance gene was driven by the Rous sarcoma virus long terminal repeat or the herpes simplex

110 in promoter activities (but not viral murine sarcoma virus-long terminal repeat promoter activity) we

111 shown to transcriptionally activate the Rous sarcoma virus-long terminal repeat promoter, which was f

112 virus, simian virus SV40, and Moloney murine sarcoma virus (MoMSV) long terminal repeat (LTR), were u

113 ly isolated R7, a spontaneous Moloney murine sarcoma virus (MoMuSV) 124 variant.

114 emia Virus (MMLV) and the Myeloproliferative Sarcoma Virus (MPSV) long terminal repeats (LTR) or by t

115 replaced with either the myeloproliferative sarcoma virus (MPSV) or SL3-3 LTR.

116 FB27 and FB29) under the control of a murine sarcoma virus (MSV) long terminal repeat (LTR) express t

117 long terminal repeat (LTR) promoters-murine sarcoma virus (MSV), MoMLV (MLV), and the LTR (termed Rh

118 the in vitro dimerization of Moloney murine sarcoma virus (MuSV) RNA in the context of these two mod

119 In vivo screening of Rous sarcoma virus mutants was performed with randomly mutate

120 election and characterization of novel avian sarcoma virus mutants.

121 at harbor activating NRAS (Neuroblastoma Rat Sarcoma Virus) mutations.

122 site phosphorylated by gamma-PAK in the Rous sarcoma virus nucleocapsid protein NC in vivo and in vit

123 coma viral oncogene homolog B (BRAF), or rat sarcoma virus oncogene (RAS) alterations], we determined

124 audin-4, secretin receptor, claudin-7, V-ros sarcoma virus oncogene homolog 1, cadherin 22, mucin-1,

125 an (HeLa) cells, mediated by either an avian sarcoma virus or a human immune deficiency virus type 1

126 sarcoma virus such as the myeloproliferative sarcoma virus or the target cells for the two viruses we

127 le late assembly domains carried by the Rous sarcoma virus p2b protein and human immunodeficiency vir

128 an immunodeficiency virus type 1 p6, or Rous sarcoma virus p2b.

129 ting determinants involved in avian leukosis sarcoma virus packaging RNA binding to Gag protein.

130 Rous sarcoma virus pre-mRNA contains an element known as the

131 In Rous sarcoma virus, previous studies have identified importan

132 sig-mEndo expression was driven by the Rous sarcoma virus promoter had moderately high serum levels

133 om the beta-galactosidase gene when the Rous sarcoma virus promoter is used to drive transgene expres

134 enously expressing SDF-1/CXCL12 under a Rous sarcoma virus promoter were produced.

135 and CHO cells using cytomegalovirus or Rous sarcoma virus promoters.

136 Other substrates such as the Rous sarcoma virus protein NC are phosphorylated by gamma-PAK

137 ive substitutions in this region of the Rous sarcoma virus protein were lethal due to a severe defici

138 us, designated the Rasheed strain of the rat sarcoma virus (RaSV).

139 ution of a fragment of the integrase of Rous sarcoma virus (residues 49-286) containing both the cons

140 human immunodeficiency virus type 1 or Rous sarcoma virus, respectively.

141 Cell transformation by Rous sarcoma virus results in a dramatic change of adhesion s

142 ction in the total amount of HIV-1 and avian sarcoma virus retroviral vector DNA that is joined to ho

143 Rous sarcoma virus RNA contains a negative regulator of splic

144 Accumulation of unspliced Rous sarcoma virus RNA is facilitated in part by a negative c

145 2.6-fold less efficiently than genomic Rous sarcoma virus RNA.

146 or the efficient packaging of avian leukosis-sarcoma virus RNA.

147 In particular, although both Rous sarcoma virus (RSV) and AMV could replicate in cultures

148 dding of virus-like particles (VLPs) of Rous sarcoma virus (RSV) and HIV type 1 (HIV-1).

149 ane binding, we fused the MA domains of Rous sarcoma virus (RSV) and HIV-1 to the chemically inducibl

150 Gag protein; however, recent studies of Rous sarcoma virus (RSV) and human immunodeficiency virus hav

151 The Gag proteins of Rous sarcoma virus (RSV) and human immunodeficiency virus typ

152 Rous sarcoma virus (RSV) and murine leukemia virus (MLV) are

153 Rous sarcoma virus (RSV) and murine leukemia virus (MLV) Gag

154 odeficiency virus type 1 (HIV-1) and of Rous sarcoma virus (RSV) are morphologically distinct when vi

155 this question using the alpharetrovirus Rous sarcoma virus (RSV) as a model system.

156 ted to investigate the initial steps of Rous sarcoma virus (RSV) assembly by examining the associatio

157 Rous sarcoma virus (RSV) budding requires an interaction of t

158 The first few residues of the Rous sarcoma virus (RSV) CA protein comprise a structurally d

159 harged residues in the FL region of the Rous sarcoma virus (RSV) CA to particle assembly.

160 te NMR (ssNMR) resonance assignments of Rous sarcoma virus (RSV) CA, assembled into hexamer tubes tha

161 y incompetent by testing the ability of Rous sarcoma virus (RSV) CA-SP to assemble in vitro into icos

162 ty of specimens assembled in vitro from Rous sarcoma virus (RSV) CA.

163 cture of the N-terminal domain (NTD) of Rous sarcoma virus (RSV) capsid protein (CA), with an upstrea

164 During virion maturation, the Rous sarcoma virus (RSV) capsid protein is cleaved from the G

165 munodeficiency virus type 1 (HIV-1) and Rous sarcoma virus (RSV) capsid proteins form a beta-hairpin.

166 appears to be modular, as the unrelated Rous sarcoma virus (RSV) Env can be made Vpu sensitive by rep

167 We have previously described a mutant Rous sarcoma virus (RSV) Env protein, Env-mu26, with an L165R

168 model, CA proteins from both HIV-1 and Rous sarcoma virus (RSV) form similar hexagonal lattices.

169 e have identified an assembly-defective Rous sarcoma virus (RSV) Gag mutant that retains significant

170 in vitro-assembled, immature virus-like Rous sarcoma virus (RSV) Gag particles and have determined th

171 osphate [PI(3,4,5)P(3)] levels impaired Rous sarcoma virus (RSV) Gag PM localization.

172 Nucleocytoplasmic shuttling of the Rous sarcoma virus (RSV) Gag polyprotein is an integral step

173 The Rous sarcoma virus (RSV) Gag polyprotein undergoes transient

174 The Rous sarcoma virus (RSV) Gag precursor polyprotein is the onl

175 he NC domain in assembly of VLPs from a Rous sarcoma virus (RSV) Gag protein and have characterized t

176 We have purified Rous sarcoma virus (RSV) Gag protein and in parallel several

177 The first 86 residues of the Rous sarcoma virus (RSV) Gag protein form a membrane-binding

178 reported that nuclear transport of the Rous sarcoma virus (RSV) Gag protein is intrinsic to the viru

179 We discovered that the Rous sarcoma virus (RSV) Gag protein transiently localizes to

180 In the Rous sarcoma virus (RSV) Gag protein, the 25 amino-acid resid

181 In the Rous sarcoma virus (RSV) Gag protein, the M domain is contain

182 We used Rous sarcoma virus (RSV) Gag together with membrane sensors t

183 n was the 11-amino-acid p2b sequence of Rous sarcoma virus (RSV) Gag, which could fully restore HIV-1

184 tial steps in understanding the chicken Rous sarcoma virus (RSV) genome association with a nonpermiss

185 vely short, 82 nucleotide region of the Rous sarcoma virus (RSV) genome, called muPsi, was shown to b

186 The major late domain of Rous sarcoma virus (RSV) has been mapped to a PPPY motif in G

187 The L domain of Rous sarcoma virus (RSV) has been shown to interact with a ub

188 e L domains of oncoretroviruses such as Rous sarcoma virus (RSV) have a more N-terminal location and

189 We produced kinetically stabilized Rous sarcoma virus (RSV) intasomes with human immunodeficienc

190 ite-directed mutagenesis of recombinant Rous sarcoma virus (RSV) integrase (IN) allowed us to gain in

191 ed when the serine at amino acid 124 of Rous sarcoma virus (RSV) integrase is replaced by alanine, va

192 The Rous sarcoma virus (RSV) is an exception, in that its genome

193 About one-third of the MA protein in Rous sarcoma virus (RSV) is phosphorylated.

194 ve examined whether the alpharetrovirus Rous sarcoma virus (RSV) is susceptible to inhibition by a ra

195 ins that specifically interact with the Rous sarcoma virus (RSV) L domain in vitro and in vivo.

196 The discovery of Rous sarcoma virus (RSV) led to the identification of cellula

197 The Rous sarcoma virus (RSV) long terminal repeat (LTR) contains

198 The Rous sarcoma virus (RSV) long terminal repeat (LTR) contains

199 rus (CMV) immediate-early promoter, the Rous sarcoma virus (RSV) long terminal repeat, and the adenov

200 ation of HIV-1 Gag, as well as purified Rous sarcoma virus (RSV) MA and Gag, depends strongly on the

201 tro flotation assay to directly measure Rous sarcoma virus (RSV) MA-membrane interaction in the absen

202 repeat (IR) within the U5 region of the Rous sarcoma virus (RSV) mRNA forms a structure composed of a

203 In this report, a Rous sarcoma virus (RSV) mutant having two acidic-to-basic su

204 The Rous sarcoma virus (RSV) negative regulator of splicing (NRS)

205 ty compared with strong but nonspecific rous sarcoma virus (RSV) or cytomegalovirus promoters.

206 The late assembly domain (L-domain) of Rous sarcoma virus (RSV) or human immunodeficiency virus type

207 f Gag in in vivo and in vitro assembled Rous sarcoma virus (RSV) particles and to compare these featu

208 er, in the presence of budding HIV-1 or Rous sarcoma virus (RSV) particles, some glycoproteins, such

209 The Rous sarcoma virus (RSV) polyadenylation site (PAS) is very p

210 deficiency virus type 1 (HIV-1) PTAP or Rous sarcoma virus (RSV) PPPY L domain in the p9 protein or b

211 enzymatic and structural properties of Rous sarcoma virus (RSV) PR are exquisitely sensitive to muta

212 e gene under the control of a truncated Rous sarcoma virus (RSV) promoter (AdRSVpHyde) was generated.

213 NA for human iNOS was cloned behind the Rous sarcoma virus (RSV) promoter to create adenovirus (Ad) 5

214 Rous sarcoma virus (RSV) promoter-driven expression of the FR

215 us containing the HERG gene driven by a Rous sarcoma virus (RSV) promoter.

216 l of the human cytomegalovirus (CMV) or Rous sarcoma virus (RSV) promoters.

217 initiated by electroporation of cloned Rous sarcoma virus (RSV) proviral DNA into the developing chi

218 xpression of the Gag-Pol polyprotein of Rous sarcoma virus (RSV) requires a -1 ribosomal frameshiftin

219 Rous sarcoma virus (RSV) requires large amounts of unspliced

220 We asked whether a single Rous sarcoma virus (RSV) RNA can be translated and subsequent

221 g site in the 5' untranslated region of Rous sarcoma virus (RSV) RNA play an integral role in multipl

222 We previously identified the Rous sarcoma virus (RSV) stability element (RSE), an RNA elem

223 se monoclonal antibody directed against Rous sarcoma virus (RSV) subgroup A Env that will be useful i

224 uce milligram quantities of the soluble Rous sarcoma virus (RSV) synaptic complex that is kinetically

225 ibes new mutations in the CA protein of Rous sarcoma virus (RSV) that were designed to test whether t

226 chick embryo fibroblasts transformed by Rous sarcoma virus (RSV) the tyrosine phosphorylation of a ce

227 eline immunodeficiency virus (FIV), and Rous sarcoma virus (RSV) to critically address the role of in

228 The Rous sarcoma virus (RSV) transmembrane (TM) glycoprotein is m

229 ansport, the multidomain Gag protein of Rous sarcoma virus (RSV) undergoes importin-mediated nuclear

230 ys3) as the replication primer, whereas Rous sarcoma virus (RSV) uses tRNA(Trp).

231 overy from Ray Erikson's group that the Rous sarcoma virus (RSV) v-Src-transforming protein had an as

232 ctor containing a constitutively active Rous sarcoma virus (RSV) viral promoter driving the luciferas

233 A PPPPY motif within the L domain of Rous sarcoma virus (RSV) was previously characterized as bein

234 ctions with purified CA proteins of the Rous sarcoma virus (RSV) were used to define factors that inf

235 We previously reported that a mutant Rous sarcoma virus (RSV) with an alternate polypurine tract (

236 Rous sarcoma virus (RSV), a simple retrovirus, needs to expor

237 bles the PPPPY motif in the L domain of Rous sarcoma virus (RSV), an avian retrovirus.

238 1, Moloney murine leukemia virus (MLV), Rous sarcoma virus (RSV), and human T-cell lymphotropic virus

239 immunodeficiency virus type 1 (HIV-1), Rous sarcoma virus (RSV), and Mason-Pfizer monkey virus (MPMV

240 les of the prototypic avian retrovirus, Rous sarcoma virus (RSV), by using scanning transmission elec

241 In some orthoretroviruses, including Rous Sarcoma Virus (RSV), CA carries a short and hydrophobic

242 ous recovered a virus, now known as the Rous sarcoma virus (RSV), from a chicken sarcoma, which repro

243 For Rous sarcoma virus (RSV), Gag proteins are synthesized in the

244 based on the existence of MA mutants in Rous sarcoma virus (RSV), murine leukemia virus, human immuno

245 During assembly and morphogenesis of Rous sarcoma virus (RSV), proteolytic processing of the struc

246 For Rous sarcoma virus (RSV), the size determinant maps to the ca

247 In the case of Rous sarcoma virus (RSV), the size determinant maps to the CA

248 ammaretrovirus, and the Alpharetrovirus Rous sarcoma virus (RSV), were susceptible to inhibition by R

249 ation-competent shuttle vector based on Rous sarcoma virus (RSV), with alternate retroviral PPTs and

250 utility of the system, we developed new Rous sarcoma virus (RSV)-based replication-incompetent vector

251 the PBS and the CA dinucleotide of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z to match the

252 ndogenous polypurine tract (PPT) of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z was replaced

253 in the 5' end of the U3 sequence of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z.

254 ishment of the transformed phenotype in Rous sarcoma virus (RSV)-infected cells.

255 or encoding a peptide inhibitor of PKA [Rous sarcoma virus (RSV)-protein kinase A inhibitor (PKI)].

256 Rous sarcoma virus (RSV)-tk bearing the HSV1-tk gene were adm

257 obustly induced enzymatic activities in Rous sarcoma virus (RSV)-transformed chicken cells.

258 found in osteoclasts, macrophages, and Rous sarcoma virus (RSV)-transformed fibroblasts.

259 well-established retroviral model-avian Rous sarcoma virus (RSV)-we analyzed changes in an RSV varian

260 s of study on an avian RNA tumor virus, Rous sarcoma virus (RSV).

261 embryo fibroblasts (CEF) infected with Rous sarcoma virus (RSV).

262 retroviral envelope protein (EnvA) from Rous sarcoma virus (RSV).

263 1-dependent nuclear cycling was that of Rous sarcoma virus (RSV).

264 rane interaction of the alpharetrovirus Rous sarcoma virus (RSV).

265 man immunodeficiency virus (HIV) RT or avian sarcoma virus RT.

266 parate structural alignment of HIV-1, simian sarcoma virus (SIV), and avian sarcoma virus (ASV) INs p

267 In Rous sarcoma virus, splicing control is achieved in part thro

268 sequence of the Atlantic salmon swim bladder sarcoma virus (SSSV) provirus is 10.9 kb in length and s

269 also found for other retroviruses, the Rous sarcoma virus structural protein Gag is necessary and su

270 express TVA, the receptor for avian leukosis sarcoma virus subgroup A (ALSV-A), under the control of

271 uced with Friend virus suggested that either sarcoma virus such as the myeloproliferative sarcoma vir

272 gative regulator of splicing (NRS) from Rous sarcoma virus suppresses viral RNA splicing and is one o

273 RS) is a long cis-acting RNA element in Rous sarcoma virus that contributes to unspliced RNA accumula

274 ant of the viral matrix (MA) protein of Rous sarcoma virus that disrupts viral RNA dimerization.

275 d cryo-electron tomography to visualize Rous sarcoma virus, the prototypic alpharetrovirus.

276 nd nonreceptor tyrosine kinase Src from Rous sarcoma virus, these interactions are mediated by an N-t

277 In HIV-1 and Rous sarcoma virus, this region forms a rod-like structure th

278 s antisense, can inhibit replication of Rous sarcoma virus through hybridization to viral RNA.

279 1 (HcrtR1/OX(1)R) but not to Kirsten murine sarcoma virus transformed rat kidney epithelial (KNRK) c

280 ially identified as a phosphoprotein in Rous sarcoma virus-transformed cells.

281 subunit (Na,K-beta) in highly motile Moloney sarcoma virus-transformed Madin-Darby canine kidney (MSV

282 Moloney sarcoma virus-transformed Madin-Darby canine kidney cell

283 Moloney sarcoma virus-transformed MDCK cells (MSV-MDCK) express

284 In simian sarcoma virus-transformed NIH 3T3 cells (SSV-NIH 3T3 cel

285 s containing the cellular receptors for Rous sarcoma virus (Tva) or ecotropic murine leukemia virus (

286 composed of a Tec-homology (TH) domain and a sarcoma virus tyrosine kinase (Src)-homology 3 (SH3) dom

287 yo fibroblasts (CEF) infected with the avian sarcoma virus UR2, encoding the oncogenic receptor prote

288 We find that Rous sarcoma virus virions, like the human immunodeficiency v

289 s discovery of reverse transcriptase in Rous sarcoma virus virions.

290 By cryoelectron tomography, Rous sarcoma virus VLPs show an organized hexameric lattice c

291 Walleye dermal sarcoma virus (WDSV) encodes an accessory protein, OrfA,

292 Walleye dermal sarcoma virus (WDSV) infection is associated with the se

293 Walleye dermal sarcoma virus (WDSV) is a complex retrovirus associated

294 Walleye dermal sarcoma virus (WDSV) is a complex retrovirus found assoc

295 Walleye dermal sarcoma virus (WDSV), a retrovirus distantly related to

296 ounding member of this group, walleye dermal sarcoma virus (WDSV), induces benign skin tumors in the

297 related to one another and to walleye dermal sarcoma virus (WDSV).

298 including the prototypic oncoretrovirus Rous sarcoma virus, were synthesized on cytosolic ribosomes a

299 The discovery of Rous sarcoma virus, which was reported by Peyton Rous in the

300 and CaCo2) compared with a nonspecific Rous sarcoma virus-yCD virus.